F121 - A Practical Approach to Adult and Pediatric Autoimmune Connective Tissue Diseases
Monday, March 4; 1:00 PM - 3:00 PM
Following this course, the attendee should be able to:
- Utilize clinical examination to aid in accurate diagnosis of autoimmune connective tissue disease.
- Formulate an algorithm for appropriate work-up of autoimmune connective tissue diseases.
- Develop management strategies for autoimmune connective tissue diseases.
Autoimmune connective tissue diseases can have devastating consequences on morbidity and mortality in both the pediatric and adult population. Due to the rarity of many of these conditions, the paucity of Level 1 evidence guiding work-up and management, and the frequent need for chronic immunosuppressive therapy, many challenges exist when managing these conditions. This session will focus on diagnosis, work-up, and management of challenging adult and pediatric autoimmune connective tissue diseases seen in dermatology-rheumatology clinics, and will include an interactive discussion of sclerosing disorders, lupus erythematosus, dermatomyositis, as well as other conditions in the dermatology-rheumatology domain.
- Femia, Alisa, MD: no financial relationships exist with commercial interests.
- Oza, Vikash Sudhir, MD: Pfizer Inc. – A(Fees); Regeneron Pharmaceuticals, Inc. – A(Fees);
- Winterfield, Laura S., MD: Eli Lilly and Company – I(NC);
Dr. Femia / Cutaneous lupus
Dr. Winterfield / Pyoderma Gangrenosum
/ Cutaneous Dermatomyositis
Dr. Femia / Sclerosing Conditions
Dr. Oza / Pediatric Connective Tissue Disease
All faculty / Question & Answer